NCT00287521

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 87 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Conditions

• Open-angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	AL-37807 Ophthalmic Suspension, 1.0%	One drop in the study eye(s) once daily for 28 days
DRUG	Latanoprost, 0.005% (Xalatan)	One drop in the study eye(s) once daily for 28 days
OTHER	AL-37807 Vehicle	One drop in the study eye(s) once daily for 28 days
DRUG	Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%	One drop in the study eye(s) once daily for 28 days

Timeline

• Start date: 2005-11-01
• Primary completion: 2006-02-01
• Completion: 2006-02-01
• First posted: 2006-02-07
• Last updated: 2012-03-05

Locations

1 site across 1 country: United States